{
  "paper_id": "6afffae2215078ac8cc1a671b221fce759392b0f",
  "metadata": {
    "title": "Relevance of feline interferon omega for clinical improvement and reduction of concurrent viral excretion in retrovirus infected cats from a rescue shelter q",
    "coda_data_split": "test",
    "coda_paper_id": 243,
    "coda_has_expert_labels": false,
    "subset": "custom_license"
  },
  "abstract": [
    {
      "original_text": "Feline Immnunodeficiency (FIV) and Feline Leukemia (FeLV) viruses are common infectious agents in stray cats and shelter environments. Recombinant feline interferon-x (rFeIFNx) has shown an antiviral action not only against FIV and FeLV but also against herpesvirus (FHV-1) and calicivirus (FCV).",
      "sentences": [
        [
          {
            "segment_text": "Feline Immnunodeficiency ( FIV ) and Feline Leukemia ( FeLV ) viruses are common infectious agents in stray cats and shelter environments .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "Recombinant feline interferon-x ( rFeIFNx ) has shown an antiviral action not only against FIV and FeLV but also against herpesvirus ( FHV-1 ) and calicivirus ( FCV ) .",
            "crowd_label": "background"
          }
        ]
      ]
    },
    {
      "original_text": "Sixteen naturally infected FIV/FeLV cats were followed during rFeIFNx therapy in order to monitor clinical signs and to correlate with excretion of concomitant viruses (FCV, FHV-1, feline coronavirus (FCoV) and parvovirus (FPV)). Cats were submitted to clinical evaluations and concomitant virus excretion assessement.",
      "sentences": [
        [
          {
            "segment_text": "Sixteen naturally infected FIV/FeLV cats were followed during rFeIFNx therapy in order to monitor clinical signs and to correlate with excretion of concomitant viruses ( FCV , FHV-1 , feline coronavirus ( FCoV ) and parvovirus ( FPV ) ) .",
            "crowd_label": "method"
          }
        ],
        [
          {
            "segment_text": "Cats were submitted to clinical evaluations and concomitant virus excretion assessement .",
            "crowd_label": "method"
          }
        ]
      ]
    },
    {
      "original_text": "Comparing D0-D65, 10/16 cats improved clinical scores. Of the 10 cats positive for FHV-1 on D0, 4 were negative and 6 reduced viral loads. Of the 11 FCoV positive cats, 9 reduced viral loads. The 13 FCV positive cats and the FPV positive cat were negative on D65.",
      "sentences": [
        [
          {
            "segment_text": "Comparing D0-D65 , 10/16 cats improved clinical scores .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "Of the 10 cats positive for FHV-1 on D0 ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "4 were negative and 6 reduced viral loads .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "Of the 11 FCoV positive cats , 9 reduced viral loads .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "The 13 FCV positive cats and the FPV positive cat were negative on D65 .",
            "crowd_label": "finding"
          }
        ]
      ]
    },
    {
      "original_text": "In conclusion, rFeIFNx improves clinical signs and reduces concurrent viral excretion in naturally infected retroviral cats.",
      "sentences": [
        [
          {
            "segment_text": "In conclusion , rFeIFNx improves clinical signs and reduces concurrent viral excretion in naturally infected retroviral cats .",
            "crowd_label": "finding"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "4",
    "sentence_num": "9",
    "segment_num": "10",
    "token_num": "179"
  }
}